Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000196494 | SCV000250147 | uncertain significance | not provided | 2021-02-12 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Does not affect a cysteine residue within a calcium-binding EGF-like domain of the FBN2 gene; cysteine substitutions in the calcium-binding EGF-like domains represent the majority of pathogenic missense changes associated with FBN2-related disorders (Collod-Beroud et al., 2003; Frederic et al., 2009); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 213265; Landrum et al., 2016) |
Ce |
RCV000196494 | SCV001245738 | uncertain significance | not provided | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001853141 | SCV002156084 | likely benign | Congenital contractural arachnodactyly | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020357 | SCV005018102 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-03-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |